ATE422900T1 - Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthält - Google Patents
Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthältInfo
- Publication number
- ATE422900T1 ATE422900T1 AT04018329T AT04018329T ATE422900T1 AT E422900 T1 ATE422900 T1 AT E422900T1 AT 04018329 T AT04018329 T AT 04018329T AT 04018329 T AT04018329 T AT 04018329T AT E422900 T1 ATE422900 T1 AT E422900T1
- Authority
- AT
- Austria
- Prior art keywords
- producing
- bordetella pertussis
- vaccine containing
- pertussis antigens
- cellular vaccine
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 241000588832 Bordetella pertussis Species 0.000 title abstract 2
- 229940030156 cell vaccine Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 abstract 2
- 201000005702 Pertussis Diseases 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Liquid Crystal Substances (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898910570A GB8910570D0 (en) | 1989-05-08 | 1989-05-08 | Acellular vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE422900T1 true ATE422900T1 (de) | 2009-03-15 |
Family
ID=10656410
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96112324T ATE276759T1 (de) | 1989-05-08 | 1990-04-26 | Azellulärer impfstoff |
| AT90907222T ATE147271T1 (de) | 1989-05-08 | 1990-04-26 | Azellulärer impfstoff |
| AT04018329T ATE422900T1 (de) | 1989-05-08 | 1990-04-26 | Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthält |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96112324T ATE276759T1 (de) | 1989-05-08 | 1990-04-26 | Azellulärer impfstoff |
| AT90907222T ATE147271T1 (de) | 1989-05-08 | 1990-04-26 | Azellulärer impfstoff |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7479283B1 (de) |
| EP (3) | EP1666057B1 (de) |
| JP (2) | JP3281369B2 (de) |
| AT (3) | ATE276759T1 (de) |
| DE (14) | DE122005000019I1 (de) |
| DK (3) | DK1666057T3 (de) |
| ES (3) | ES2095874T5 (de) |
| FR (1) | FR09C0033I1 (de) |
| GB (1) | GB8910570D0 (de) |
| LU (15) | LU90204I2 (de) |
| NL (13) | NL980007I1 (de) |
| WO (1) | WO1990013313A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8412207D0 (en) * | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
| GB8910570D0 (en) | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
| EP0484621A3 (en) * | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
| GB9021004D0 (en) * | 1990-09-27 | 1990-11-07 | Wellcome Found | Acellular vaccines |
| GB9209118D0 (en) * | 1992-04-28 | 1992-06-10 | Sb 120 Amsterdam Bv | Vaccine compositions |
| FR2754543B1 (fr) * | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
| US7022522B2 (en) | 1998-11-13 | 2006-04-04 | Limin Guan | Macroporous polymer scaffold containing calcium phosphate particles |
| RU2148412C1 (ru) * | 1999-08-06 | 2000-05-10 | Москаленко Екатерина Петровна | Способ получения протективного коклюшного антигена |
| EP1667712B1 (de) * | 2003-10-02 | 2010-07-21 | GlaxoSmithKline Biologicals S.A. | B. pertussis antigene und ihre verwendung bei der vakzinierung |
| US8877201B2 (en) * | 2007-10-25 | 2014-11-04 | Wake Forest University Health Sciences | Bordetella outer-membrane protein antigens and methods of making and using the same |
| JP6134470B2 (ja) | 2008-03-07 | 2017-05-24 | アーケマ・インコーポレイテッド | クロロ−3,3,3−トリフルオロプロペンによる安定した処方系 |
| GB201105981D0 (en) | 2011-04-08 | 2011-05-18 | Glaxosmithkline Biolog Sa | Novel process |
| EP2863943B1 (de) | 2013-03-08 | 2016-07-13 | Crucell Holland B.V. | Nicht zellulärer pertussis-impfstoff |
| CA2923129C (en) | 2013-09-08 | 2020-06-09 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| WO2016132294A1 (en) | 2015-02-19 | 2016-08-25 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2047886A1 (en) | 1969-06-30 | 1971-03-19 | Merieux Inst | Non-toxic anti-whooping cough vaccine |
| DE3176347D1 (en) | 1980-06-27 | 1987-09-17 | Ciba Geigy Ag | Synergistic agents and method for the selective control of weeds, particularly in cereals and soybeans |
| JPS5750925A (en) | 1980-09-12 | 1982-03-25 | Takeda Chem Ind Ltd | Preparation of pertussis toxoid |
| JPS58222032A (ja) | 1982-06-18 | 1983-12-23 | Teijin Ltd | 百日咳毒素のサブユニツト蛋白 |
| US5237052A (en) * | 1984-05-12 | 1993-08-17 | Burroughs Wellcome Company | Antigenic preparations and isolation of such preparations |
| GB8412207D0 (en) | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
| JPS6176422A (ja) * | 1984-09-22 | 1986-04-18 | Chemo Sero Therapeut Res Inst | 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法 |
| FR2590483B1 (fr) | 1985-11-22 | 1988-12-09 | Pasteur Institut | Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant |
| GB8601279D0 (en) * | 1986-01-20 | 1986-02-26 | Public Health Lab Service | Purification of pertussis antigens |
| DE3783869D1 (de) * | 1986-11-11 | 1993-03-11 | Siemens Ag | Flusskompensierter stromwandler. |
| EP0267998A1 (de) * | 1986-11-17 | 1988-05-25 | Institut Pasteur | Mittel zur Unterstützung gegen Infektion und Vergiftung von Bordetella |
| FR2606789B1 (fr) | 1986-11-17 | 1991-05-31 | Pasteur Institut | Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques |
| US5358868A (en) * | 1987-11-24 | 1994-10-25 | Connaught Laboratories Limited | Genetic detoxification of pertussis toxin |
| GB8807860D0 (en) * | 1988-04-05 | 1988-05-05 | Connaught Lab | Pertussis vaccine |
| US5101014A (en) * | 1989-02-10 | 1992-03-31 | United States Of America | Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis |
| US5162223A (en) * | 1989-02-17 | 1992-11-10 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Resources | Hybridomas and resulting monoclonal antibodies directed against antigens of Bordetella pertussis |
| GB8910570D0 (en) | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
| US5276142A (en) * | 1989-12-11 | 1994-01-04 | American Cyanamid Company | Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis |
| GB9007416D0 (en) | 1990-04-02 | 1990-05-30 | Wellcome Found | Expression of heterologous protein in yeast |
| GB9007657D0 (en) | 1990-04-04 | 1990-05-30 | Connaught Lab | Purification of a pertussis outer membrane protein(omp69) |
| IT1248735B (it) | 1990-06-21 | 1995-01-26 | Sclavo Spa | Vaccini acellulari contro la pertosse |
| EP0484621A3 (en) | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
| US6051240A (en) | 1994-04-28 | 2000-04-18 | Takeda Chemical Industries, Ltd. | Method of separating protective components of Bordetella pertussis |
| US5972225A (en) * | 1996-05-07 | 1999-10-26 | Cook Imaging Corporation | Process for remediating endotoxin-contaminated bulk non-ionic contrast media |
-
1989
- 1989-05-08 GB GB898910570A patent/GB8910570D0/en active Pending
-
1990
- 1990-04-26 DE DE200512000019 patent/DE122005000019I1/de active Pending
- 1990-04-26 ES ES90907222T patent/ES2095874T5/es not_active Expired - Lifetime
- 1990-04-26 AT AT96112324T patent/ATE276759T1/de active
- 1990-04-26 AT AT90907222T patent/ATE147271T1/de active
- 1990-04-26 EP EP04018329A patent/EP1666057B1/de not_active Expired - Lifetime
- 1990-04-26 EP EP96112324A patent/EP0747058B1/de not_active Revoked
- 1990-04-26 DE DE200512000018 patent/DE122005000018I1/de active Pending
- 1990-04-26 WO PCT/GB1990/000649 patent/WO1990013313A1/en not_active Ceased
- 1990-04-26 DE DE122009000042C patent/DE122009000042I1/de active Pending
- 1990-04-26 DE DE200512000016 patent/DE122005000016I1/de active Pending
- 1990-04-26 DE DE122009000041C patent/DE122009000041I1/de active Pending
- 1990-04-26 EP EP90907222A patent/EP0471726B2/de not_active Expired - Lifetime
- 1990-04-26 ES ES96112324T patent/ES2230555T3/es not_active Expired - Lifetime
- 1990-04-26 DE DE122009000044C patent/DE122009000044I1/de active Pending
- 1990-04-26 ES ES04018329T patent/ES2322352T3/es not_active Expired - Lifetime
- 1990-04-26 DE DE200512000017 patent/DE122005000017I1/de active Pending
- 1990-04-26 DE DE200512000014 patent/DE122005000014I1/de active Pending
- 1990-04-26 DK DK04018329T patent/DK1666057T3/da active
- 1990-04-26 DK DK96112324T patent/DK0747058T3/da active
- 1990-04-26 DE DE69034166T patent/DE69034166T2/de not_active Expired - Lifetime
- 1990-04-26 DE DE69034264T patent/DE69034264D1/de not_active Expired - Lifetime
- 1990-04-26 DE DE200512000020 patent/DE122005000020I1/de active Pending
- 1990-04-26 DE DE69029656T patent/DE69029656T3/de not_active Expired - Lifetime
- 1990-04-26 DK DK90907222T patent/DK0471726T4/da active
- 1990-04-26 DE DE122009000043C patent/DE122009000043I1/de active Pending
- 1990-04-26 AT AT04018329T patent/ATE422900T1/de active
- 1990-04-26 JP JP50666890A patent/JP3281369B2/ja not_active Expired - Lifetime
-
1995
- 1995-05-25 US US08/450,336 patent/US7479283B1/en not_active Expired - Lifetime
-
1998
- 1998-01-27 NL NL980007C patent/NL980007I1/nl unknown
- 1998-01-28 LU LU90204C patent/LU90204I2/fr unknown
-
2002
- 2002-01-09 JP JP2002002530A patent/JP2002226397A/ja active Pending
-
2004
- 2004-10-28 DE DE200512000015 patent/DE122005000015I1/de active Pending
-
2005
- 2005-03-22 LU LU91153C patent/LU91153I2/fr unknown
- 2005-03-22 LU LU91152C patent/LU91152I2/fr unknown
- 2005-03-22 NL NL300184C patent/NL300184I1/nl unknown
- 2005-03-22 LU LU91151C patent/LU91151I2/fr unknown
- 2005-03-22 LU LU91155C patent/LU91155I2/fr unknown
- 2005-03-22 LU LU91154C patent/LU91154I2/fr unknown
- 2005-03-22 NL NL300186C patent/NL300186I1/nl unknown
- 2005-03-22 LU LU91150C patent/LU91150I2/fr unknown
- 2005-03-22 NL NL300187C patent/NL300187I1/nl unknown
- 2005-03-22 NL NL300185C patent/NL300185I1/nl unknown
- 2005-03-22 NL NL300189C patent/NL300189I1/nl unknown
- 2005-03-22 NL NL300188C patent/NL300188I1/nl unknown
- 2005-03-22 NL NL300183C patent/NL300183I1/nl unknown
- 2005-03-22 LU LU91149C patent/LU91149I2/fr unknown
-
2009
- 2009-08-11 NL NL300400C patent/NL300400I1/nl unknown
- 2009-08-11 NL NL300404C patent/NL300404I1/nl unknown
- 2009-08-11 NL NL300403C patent/NL300403I1/nl unknown
- 2009-08-11 NL NL300402C patent/NL300402I1/nl unknown
- 2009-08-11 NL NL300401C patent/NL300401I1/nl unknown
- 2009-08-12 LU LU91596C patent/LU91596I2/fr unknown
- 2009-08-12 LU LU91593C patent/LU91593I2/fr unknown
- 2009-08-12 LU LU91592C patent/LU91592I2/fr unknown
- 2009-08-12 LU LU91594C patent/LU91594I2/fr unknown
- 2009-08-12 LU LU91591C patent/LU91591I2/fr unknown
- 2009-08-12 LU LU91597C patent/LU91597I2/fr unknown
- 2009-08-12 LU LU91595C patent/LU91595I2/fr unknown
- 2009-08-13 FR FR09C0033C patent/FR09C0033I1/fr active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300400I1 (en) | Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens | |
| NL980006I1 (nl) | Antigeen-preparaten en isolering van dergelijke preparaten. | |
| ATE159758T1 (de) | Azelluläre impfstoffe |